Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Yared Gurmu"'
Autor:
Brian A. Bergmark, Deepak L. Bhatt, P. Gabriel Steg, Andrzej Budaj, Robert F. Storey, Yared Gurmu, Julia F. Kuder, KyungAh Im, Giulia Magnani, Ton Oude Ophuis, Christian Hamm, Jindřich Špinar, Robert G. Kiss, Frans J. Van de Werf, Gilles Montalescot, Per Johanson, Eugene Braunwald, Marc S. Sabatine, Marc P. Bonaca
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 17 (2021)
Background Coronary stent type and risk of stent thrombosis remain important factors affecting recommended duration of dual antiplatelet therapy. We investigated the efficacy and safety of long‐term ticagrelor in patients with prior coronary stenti
Externí odkaz:
https://doaj.org/article/762a1c5fb8704c70a586ea0ee8b0dab0
Autor:
Baris Gencer, Xinmin S. Li, Yared Gurmu, Marc P. Bonaca, David A. Morrow, Marc Cohen, Deepak L. Bhatt, P. Gabriel Steg, Robert F. Storey, Per Johanson, Zeneng Wang, Stanley L. Hazen, Marc S. Sabatine
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 10 (2020)
Background Trimethylamine N‐oxide (TMAO) may have prothrombotic properties. We examined the association of TMAO quartiles with major adverse cardiovascular events (MACE) and the effect of TMAO on the efficacy of ticagrelor. Methods and Results PEGA
Externí odkaz:
https://doaj.org/article/257a96ac3be84083853f101c655a058b
Autor:
Remo H. M. Furtado, Ramkumar V. Venkateswaran, Jose C. Nicolau, Yared Gurmu, Deepak L. Bhatt, Robert F. Storey, P. Gabriel Steg, Giuglia Magnani, Shinya Goto, Mikael Dellborg, Gabriel Kamensky, Daniel Isaza, Philip Aylward, Per Johanson, Marc P. Bonaca
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 10 (2020)
Background A proposed cause of dyspnea induced by ticagrelor is an increase in adenosine blood levels. Because caffeine is an adenosine antagonist, it can potentially improve drug tolerability with regard to dyspnea. Furthermore, association between
Externí odkaz:
https://doaj.org/article/6384ab839e054078afa8fae396ae37f5
Autor:
Linda Valeri, Oscar Patterson-Lomba, Yared Gurmu, Akweley Ablorh, Jennifer Bobb, F William Townes, Guy Harling
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0163544 (2016)
BACKGROUND:The recent Ebola virus disease (EVD) outbreak in West Africa has spread wider than any previous human EVD epidemic. While individual-level risk factors that contribute to the spread of EVD have been studied, the population-level attributes
Externí odkaz:
https://doaj.org/article/e89c226c04714f958bbb63cee32262c3
Autor:
Benjamin M. Scirica, Christian T. Ruff, Robert P. Giugliano, Christopher P. Cannon, Peter S. Sever, Eugene Braunwald, Robert F. Storey, Frederick K. Kamanu, Marc S. Sabatine, Yared Gurmu, Steven A. Lubitz, Christopher D. Anderson, Elliott M. Antman, Parth N Patel, Marc P. Bonaca, Philippe Gabriel Steg, Patrick T. Ellinor, Michelle L. O'Donoghue, Lu-Chen Weng, Anthony C Keech, Itamar Raz, Ofri Mosenzon, Marc Cohen, Deepak L. Bhatt, Francesco Nordio, Nicholas A Marston, Carolina Roselli, Giorgio M. Melloni
Publikováno v:
Circulation
Background: Genome-wide association studies have identified single-nucleotide polymorphisms that are associated with an increased risk of stroke. We sought to determine whether a genetic risk score (GRS) could identify subjects at higher risk for isc
Autor:
Ofri Mosenzon, Marc P. Bonaca, Ilaria Cavallari, Anthony C Keech, Itamar Raz, Marc Cohen, Philippe Gabriel Steg, Nicholas A Marston, Yared Gurmu, Marc S. Sabatine, Robert F. Storey, Carolina Roselli, Giorgio E. M. Melloni, Benjamin M. Scirica, Deepak L. Bhatt, Patrick T. Ellinor, Christina J.-Y. Lee, Frederick K. Kamanu, Christian T. Ruff, Robert P. Giugliano, Eugene Braunwald, Steven A. Lubitz
Publikováno v:
Circulation-Genomic and precision medicine, 14(1):e003006, 82-87. LIPPINCOTT WILLIAMS & WILKINS
Circ Genom Precis Med
Circ Genom Precis Med
Background: Venous thromboembolism (VTE) is a major cause of cardiovascular morbidity and mortality and has a known genetic contribution. We tested the performance of a genetic risk score for its ability to predict VTE in 3 cohorts of patients with c
Autor:
Anuradha Lala, Sean Pinney, David D. Berg, Eric J. Velazquez, Adam D. DeVore, David A. Morrow, Yared Gurmu, Eugene Braunwald, Carol I. Duffy
Publikováno v:
JACC Heart Fail
Objectives This study sought to evaluate the efficacy and safety of sacubitril/valsartan according to dose level achieved in the PIONEER-HF (Comparison of Sacubitril/Valsartan Versus Enalapril on Effect on NT-proBNP in Patients Stabilized From an Acu
Autor:
Christian T. Ruff, Anthony C Keech, Nicholas A Marston, Robert P. Giugliano, Giorgio E. M. Melloni, Marc S. Sabatine, Terje R. Pedersen, Yared Gurmu, Peter S. Sever, Baris Gencer, Marc P. Bonaca, Carolina Roselli, Patrick T. Ellinor, Michelle L. O'Donoghue, Steven A. Lubitz
Publikováno v:
Circulation, 141(20), 1600-1607. LIPPINCOTT WILLIAMS & WILKINS
Background: The relationship between cholesterol levels and risk of venous thromboembolism (VTE) is uncertain. We set out to determine the effect of PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibition on the risk of VTE, explore potentia
Autor:
Marc S. Sabatine, Huei Wang, Terje R. Pedersen, Frederick K. Kamanu, Anthony C Keech, Yared Gurmu, Francesco Nordio, Nicholas A Marston, Steven A. Lubitz, Carolina Roselli, Christian T. Ruff, Robert P. Giugliano, Patrick T. Ellinor, Peter S. Sever, Armando Lira Pineda
Publikováno v:
Circulation
Circulation, 141(8), 616-623. LIPPINCOTT WILLIAMS & WILKINS
Circulation, 141(8), 616-623. LIPPINCOTT WILLIAMS & WILKINS
Background: The ability of a genetic risk score to predict risk in established cardiovascular disease and identify individuals who derive greater benefit from PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibition has not been established.
Autor:
Ofri Mosenzon, Darren K. McGuire, Lawrence A. Leiter, Itamar Raz, Stephen D. Wiviott, Per Johanson, Yared Gurmu, Peter A. Johansson, Sabina A. Murphy, Marc S. Sabatine, David D. Berg, Anna Maria Langkilde, Benjamin M. Scirica, Deepak L. Bhatt, John P.H. Wilding, Eugene Braunwald
Publikováno v:
Circulation
Background: Patients with type 2 diabetes mellitus (T2DM) are at increased risk of developing heart failure. Sodium-glucose cotransporter-2 inhibitors reduce the risk of hospitalization for heart failure (HHF) in patients with T2DM. We aimed to devel